| HOME |
Research Database -
International Updates
Pregnancy / Menstruation
Issue 30
ESKELAND and colleagues, Department of Public Health and
Primary Health Care, University of Bergen Norway conducted a study to evaluate the
efficacy of low-dose supplementation of iron with and
without a haeme component, prescribed for women in the second half of their
pregnancy. METHODS: 90 women participated in a randomised, double-blind placebo
controlled trial and were randomised into 3 groups: 1) 31 women received a daily dose of
27 mg elemental iron supplement (Hemofer) containing both haeme and non-haeme 2) 30 women
received the same dose as pure non-haeme iron with vitamin C (Collets) and 29 women
received placebo. The tablets were masked using a double dummy technique. The women were
tested for red cell indices and the iron status markers s-ferritin, s-iron, Total Iron
Binding Capacity and red blood cell protoporphyrin through their pregnancy and 8 and 24
weeks after giving birth. Results were analysed according to intention to
treat principle> RESULTS: The haematological results were equal
in the 2 treatment groups. 52% of the women fell below 110 g/l in Haemoglobin (Hb), with
only 25% of the women in the supplemented women. No women in the supplemented groups fell
below 100 g/l, compared to 14% in the placebo group. Iron status were
significantly better for all parameters in the haeme iron group compared to placebo by the
end of pregnancy. Within the haeme iron group, there were fewer women with empty
iron stores postpartum than at the start of pregnancy (from 14% to 8%). In the non-haeme
iron group there was a significant increase from 3% to 27% and in the placebo group the
percentage of women with empty iron stores more than doubled, from 21% to 52%. CONCLUSIONS:
A daily dose of 27 mg elemental iron with haeme given in the second half of pregnancy
prevents depletion of iron stores following birth for most women.
Eskeland B et al. Iron supplementation in pregnancy: is less
enough? A randomized, placebo controlled trial of low dose iron supplementation with and
without heme iron. Acta Obstet Gynecol Scand 76 (9): 822-8. Oct
1997.
CAMPBELL and colleagues, Hunter Centre for Health Advancement, Wallsend,
New South Wales, Australia studied the rates of premenstrual symptoms, treatments
tried, perceived efficacy of such treatments, the proportion of women who sought help for
premenstrual symptoms, and whether women perceived the need for additional help in dealing
with premenstrual symptoms. METHODS: The authors conducted a cross-sectional
survey of 310 general practices patients aged 18-45 years who had had a menstrual period
in the previous three months. RESULTS: 11-32% of women reported severe or
extreme premenstrual changes regarding each of the 10 symptoms on the Premenstrual
Assessment Form, with the highest rates for affective symptoms. 85% of the women had tried
treatments for premenstrual symptoms, with many having tried a number of treatments. The
most commonly tried treatments, reported by at least 1/3 of women, included pain killers,
rest, drinking more fluids, and exercise. The most effective treatments reported included
dietary changes, evening primrose oil, vitamins including vitamin B6, and exercise. About
50% of the women had sought help, mostly from a GP 45% said that they would like more help
to deal with premenstrual symptoms. Higher symptoms scores were associated with a history
of endometriosis, lower education level, not taking oral contraceptives, taking evening
primrose oil and taking vitamin B6. CONCLUSIONS: There is a real need to
further refine programmes and resources and ways to effectively help women with
premenstrual symptoms.
Campbell EM et al. Premenstrual symptoms in general practice
patients, Prevalence and treatment. J Reperod Med 42 (10):
637-45. Oct 1997.
COMMENTS: This study reveals a rather higher proportion of women who
experience severe premenstrual symptoms. These are undoubtedly arising from rather
complicated biochemical and hormonal unbalances, which could be treated in many instances
with a combination of dietary and hormonal treatment approaches. In the recently held
Menopause Symposium hosted by Positive Health, physicians Dr John Lee, Dr Shirley Bond, Dr
David Smallbone and herbalist Dr Judy Griffin all outlined clinical programmes which can
alleviate many menstrual and menopausal symptoms. Transcripts of the Proceedings will be
available soon. Those wishing to order a copy of the Transcripts, please contact Positive
Health: Tel: 0117-983 8851 Fax: 0117-908 0097 email: sandra@positive.u-net.com.
|